Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
23 hedge funds and large institutions have $1.85M invested in Biotricity, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 10 closing their positions.
39% more capital invested
Capital invested by funds: $1.33M → $1.85M (+$523K)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
18% less funds holding
Funds holding: 28 → 23 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$62.2K |
| 2 |
Jane Street
New York
|
+$6.36K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.76K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.54K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$63 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$39K |
| 2 |
CCM
Connective Capital Management
Palo Alto,
California
|
-$35.8K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$26.6K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$22K |
| 5 |
ARC
Advisor Resource Council
Dallas,
Texas
|
-$16K |
BTCY Hedge Fund Activity: Q2 2023 in Review
23 of the 6,375 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q2 2023, worth a combined $1.85M — up 39% from $1.33M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of BTCY and 5 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was AE Wealth Management, adding an estimated $62.2K. The largest seller was BlackRock, cutting an estimated $39K.
- 23 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q2 2023, down from 28 in Q1 2023.
- Funds reported $1.85M of Biotricity, Inc. Common Stock stock for Q2 2023, up 39% quarter-over-quarter.
- 5 funds opened new Biotricity, Inc. Common Stock positions in Q2 2023 and 10 closed out, a net change of -5 holders.
- The largest Biotricity, Inc. Common Stock buyer in Q2 2023 was AE Wealth Management, an estimated $62.2K added.
- The largest Biotricity, Inc. Common Stock seller in Q2 2023 was BlackRock, an estimated $39K sold.
Based on aggregated 13F filings for Q2 2023.